Sung Hwan Moon

This inventor holds 21 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Choongwae Pharma Corporation, Aptabio Therapeutics Inc., Beijing Hanmi Pharmaceutical Co., Ltd.. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Hwan Moon. Retrieved from https://idiyas.com/inventor/sung-hwan-moon-vch3iq9f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 2)

% Patents Active = 57.1

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 121(Granted Patents)

Location History:

Kyunggi-do, KR (2007 - 2010)
Suwon-shi, KR (2004 - 2014)
Gyeonggi-do, KR (2021)
Suwon-si, KR (2015 - 2024)

Company Filing History:

13 out of 25

Choongwae Pharma Corporation

patents

6 out of 6

Aptabio Therapeutics Inc.

patents

1 out of 13

Beijing Hanmi Pharmaceutical Co., Ltd.

patents

4. 1 out of 63

Hanmi Science Co., Ltd.

patents

5. 1 out of 1

Sapphire Technology Co., Ltd.

patent

where one patent can have more than one assignee

Years Active: 2004-2026

Loading Chart...

Areas of Expertise:

Pulmonary Fibrosis

Pyrazole Derivative

Cancer Treatment

Therapeutic Agent

Liver Diseases

Guanosine-rich Oligonucleotides

Reverse-turn Mimetics

Beta-strand Mimetics

Single Crystal Sapphire

Heat Treatment Method

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12616684 - PULMONARY FIBROSIS MEDICINE CONTAINING PYRAZOLE DERIVATIVE (2026-05-05),

2. 12509438 - Pyrazole derivative (2025-12-30),

3. 11999718 - Pyrazole derivatives (2024-06-04),

4. 11174240 - Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride (2021-11-16),

5. 10966969 - Therapeutic agent for liver diseases (2021-04-06),

6. 9988741 - Heat treatment method and heat treatment device for single crystal sapphire (2018-06-05),

7. 9789202 - Method for treating cancer using an interferon alpha conjugate (2017-10-17),

8. 9056886 - Guanosine-rich modified oligonucleotides and antiproliferative activity thereof (2015-06-16),

9. 8729262 - Reverse-turn mimetics and method relating thereto (2014-05-20),

10. 8318738 - Reverse-turn mimetics and method relating thereto (2012-11-27),

11. 8138337 - Reverse-turn mimetics and method relating thereto (2012-03-20),

12. 8106049 - Reverse-turn mimetics and method relating thereto (2012-01-31),

13. 8101751 - Reverse-turn mimetics and method relating thereto (2012-01-24),

14. 7932384 - Reverse-turn mimetics and method relating thereto (2011-04-26),

15. 7671054 - Reverse-turn mimetics and method relating thereto (2010-03-02),

Title: Sung Hwan Moon - Innovative Inventor from Suwon-shi, KR

Introduction: Sung Hwan Moon is a distinguished inventor hailing from Suwon-shi, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sung Hwan Moon holds several patents in the areas of electronics, telecommunications, and renewable energy, showcasing his versatility and ingenuity in creating cutting-edge solutions.

Career Highlights: With a career spanning over two decades, Sung Hwan Moon has worked with leading tech companies, research institutions, and universities, playing a pivotal role in developing next-generation technologies that have revolutionized various industries.

Collaborations: Throughout his career, Sung Hwan Moon has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge sharing to drive progress and success in the field of technology.

Conclusion: Sung Hwan Moon's passion for innovation, coupled with his relentless pursuit of excellence, has solidified his reputation as a visionary inventor, shaping the future of technology and inspiring generations to come.

Profile summary based on public USPTO records.